Clinical trial
Efficacy of Olibra: A 12 Week Randomized Controlled Trial, and Review of Prior Studies
NCT01416051 is registered in ClinicalTrials.gov with Pennington Biomedical Research Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Olibra: A 12 Week Randomized Controlled Trial, and Review of Prior Studies
- Lead sponsor
- Pennington Biomedical Research Center
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- November 30, 2006
- Enrollment
- 82 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.